1-8 of 8
glutamate carboxypeptidase ii
Close
Sort by
Journal Articles

Interleukin 21 Enhances Survival and Expansion of CAR T Cells Via Inhibition of Their Terminal Differentiation during Interaction with Tumor Target Cells

Martin Štach, Jan Musil, Petr Cetkovsky, MD MBA, PhD, Pavel Otahal, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4545.
https://doi.org/10.1182/blood-2018-99-116294
Published: 2018
Journal Articles

Phase I/II Trial of Multi-Target Chimeric Antigen Receptor Modified T Cells (4SCAR2.0) Against Relapsed or Refractory Lymphomas

Lung-Ji Chang, PhD, Yuhua Li, MD& PhD, Sanfang Tu, MD& PhD, Xun Lai, MD, Rui Huang, MD& PhD, Shih-Ting Tsao, MSc, Yu-Chen Liu, MSc, Rui Zhang, MSc, Lan Deng, MDPhD, Xuan Zhou, MD, Hongyu Zhang, PhD MD, Wenli Zhang, MD, Yuchen Li, MSc
Journal: Blood
Blood (2018) 132 (Supplement 1): 225.
https://doi.org/10.1182/blood-2018-99-114396
Published: 2018
Journal Articles

The Role of Upfront Autologous Hematopoietic Cell Transplantation in the Treatment of Mantle Cell Lymphoma, a Population Based Study Using the National Cancer Data Base (NCDB)

Yazeed Sawalha, MD, Tomas Radivoyevitch, Katherine Tullio, Robert M. Dean, MD, Brad Pohlman, MD, Brian T. Hill, MD PhD, Matt Kalaycio, MD, Navneet S. Majhail, MD MS, Deepa Jagadeesh, MDMPH
Journal: Blood
Blood (2017) 130 (Supplement 1): 2009.
https://doi.org/10.1182/blood.V130.Suppl_1.2009.2009
Published: 2017
Journal Articles

Comparative Proteomics and Functional Analysis of Red Blood Cell Membrane Proteins in the Rare in(Lu) Blood Type

Slim Azouzi, PhD, Mahmoud Mikdar, MSc, Sara El Hoss, Alexandra Willemetz, MSc, Emilie-fleur Gautier, PhD, Patrick Mayeux, PhD, Wassim El Nemer, PhD, Yves Colin, PhD, Caroline Le Van Kim, PhD, Thierry Peyrard, PhD PharmD
Journal: Blood
Blood (2017) 130 (Supplement 1): 934.
https://doi.org/10.1182/blood.V130.Suppl_1.934.934
Published: 2017
Journal Articles

Unicar: A Novel Modular Retargeting Platform Technology for CAR T Cells

Marc Cartellieri, PhD, Simon Loff, MSc, Malte von Bonin, MD, Elham P. Bejestani, MSc, Armin Ehninger, PhD, Anja Feldmann, PhD, Stefanie Koristka, MSc, Claudia Arndt, PhD, Gerhard Ehninger, Prof., Michael P Bachmann, Prof.
Journal: Blood
Blood (2015) 126 (23): 5549.
https://doi.org/10.1182/blood.V126.23.5549.5549
Published: 2015
Journal Articles

A Phase 1 Trial of Escalating High Dose Methotrexate Supported by Glucarpidase to Treat Patients with Primary Central Nervous System Lymphoma (PCNSL). (CRUK/08/010)

Roderick J. Johnson, MD, Andrew Davies, MD, Siow-Ming Lee, MD, Dianne Gilson, MD, Paul Smith, PhD, Wendi Qian, Nivette Braganca, Nadjet El-mehidi, Peter Johnson
Journal: Blood
Blood (2012) 120 (21): 4850.
https://doi.org/10.1182/blood.V120.21.4850.4850
Published: 2012
Journal Articles

Genetically Modified DCs Engineered To Express PSA and/or PSMA Can Induce a Potent Immune Response Against Prostate Cancer Cells.

Jagdeep S. Walia, MBBS, Jianhui Cai, MDPhD, Daniel H. Fowler, MD, Jeffrey A. Medin4, PhD
Journal: Blood
Blood (2005) 106 (11): 3075.
https://doi.org/10.1182/blood.V106.11.3075.3075
Published: 2005
Journal Articles

A Phase I Open-Label Trial To Determine the Pharmacokinetics of Glucarpidase in Subjects with Normal and Impaired Renal Function.

Marc A. Phillips, PhD, Tim R. Auton, PhD, Suzanne B. Ward, PharmD, William B. Smith, MD, FACC, Guhan Balan, PhD
Journal: Blood
Blood (2005) 106 (11): 4450.
https://doi.org/10.1182/blood.V106.11.4450.4450
Published: 2005